Meghna Rao

Using data from the Ultimate I and II phase 3 trials, researchers conducted a post-hoc analysis to study the effects of ublituximab on disease activity in relapsing multiple sclerosis.

In this episode, neurologist Michael Kornberg, MD, and rheumatologist Laura C. Cappelli, MD, speak with us about how to improve the management of patients with rheumatologic conditions with neurologic manifestations.

In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.